FASLG and neoplasm: Plasma levels of reported candidate circulating tumor biomarkers SCC-Ag, cytokeratin 19 fragment (CYFRA21-1), soluble Fas (sFas), and soluble FasL (sFasL) were also analyzed and compared with those of circulating pGSN.